Vaccine production is truly international collaboration in India: EAM

Video Credit: ANI
Published on May 5, 2021 - Duration: 01:57s

Vaccine production is truly international collaboration in India: EAM

Union External Affairs Minister, Dr S Jaishankar attended a virtual conversation, called 'Global Dialogue Series' on May 05.

He said, "Our vaccine production situation was different from many other countries.

On what basis Covishield was being made in India?

It's Oxford-AstraZeneca vaccine, you can say it's British-designed product.

It was made in India as the vaccine owner saw India as an efficient production venue.

Along with that the ability and approval to make in India, came an obligation to supply it to a large part of the world.

So, people have to understand, it was not that vaccine production started in India, it was invented by an Indian, owned by an Indian, produced by an Indian." He further said, "It was a truly international collaboration.

When there is an international collaboration, if somebody gave you a vaccine to make in India, then you have to do your part, otherwise, it doesn't work.

It also came with support from the Covax initiative.

So, there was an obligation to support the Covax initiative to give vaccines at a low cost to a number of nations."

You are here

💡 newsR Knowledge: Other News Mentions

S. Jaishankar

External Affairs Minister of India, Former Indian Diplomat
If all FMs confirm the visit, this could be the first-ever in-person multilateral meet of FM of 20 countries amid a pandemic.
Credit: DNA - Published 21 hours ago

Indian external affairs minister S Jaishankar on Thursday assured the worried diaspora in Kuwait that the second wave of Covid-19 was receding in India and the..
Credit: IndiaTimes - Published 4 days ago

Oxford–AstraZeneca COVID-19 vaccine

Vaccine against COVID-19
The study was conducted on 260 health care workers who received a single dose of the Covishield vaccine between January 16 and February 5.
Credit: DNA - Published 16 hours ago

Dr VK Paul, member (Health) at NITI Aayog, said that these decisions must be taken very carefully.
Credit: DNA - Published 3 days ago

The government Friday said there is no need to panic on the need for an immediate change in the dosage interval of Covishield vaccine, underlining that reducing..
Credit: IndiaTimes - Published 4 days ago

The AIIMS study was conducted on 63 subjects who had breakthrough infections - 36 of whom had received two doses, while 27 had gotten one dose.
Credit: DNA - Published 5 days ago

University of Oxford

Collegiate research university in Oxford, England
Oxford University's vice chancellor has criticised academics for choosing to "punish students" by refusing to give tutorials in protest over a decision not to..
5 days ago • Sky News
An Oxford University students' group has voted to take down a portrait of the Queen from its common room.
1 week ago • Sky News
Covishield, from the Oxford-AstraZeneca stable, is manufactured by the Serum Institute of India in Pune. Covaxin is the indigenously manufactured vaccine by..
Credit: IndiaTimes - Published 1 week ago

Related videos from verified sources

Covid-19: Finance Ministry says, 'new vaccine plan to cost ₹ 50,000 Cr'| Oneindia News 02:19
Video credit: Oneindia - Published 1 week ago 

India's Crawling Vaccination Program | Luxury vaccination package Banned by Govt | One India News 08:22
Video credit: Oneindia - Published 2 weeks ago 

Second batch of Russia's Sputnik V Covid-19 vaccine arrives in Hyderabad, India 01:54
Video credit: Newsflare STUDIO - Published on May 16, 2021 

You might like